ReviewMolecular cancer2025

Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges.

Yuan Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.